High Net Worth Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
High Net Worth Advisory Group's PFE Position: Q3 2025 in Review
High Net Worth Advisory Group sold out of Pfizer (PFE) in Q3 2025, closing a stake of 10,066 shares — an estimated $244K sold.
High Net Worth Advisory Group first reported a position in PFE in Q4 2021 and held it in 15 quarters. The position peaked at $2.28M in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- High Net Worth Advisory Group reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- High Net Worth Advisory Group sold 10,066 Pfizer shares in Q3 2025, an estimated $244K.
- High Net Worth Advisory Group first reported a position in Pfizer in Q4 2021 and held it in 15 quarters.
- High Net Worth Advisory Group's Pfizer position peaked at $2.28M in Q4 2021.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on High Net Worth Advisory Group's 13F filing for Q3 2025, filed 29 Oct 2025.